Company intelligence / Profile preview

Tecres

Italy

Ownership: Private
Development stage: Other

Overview

Tecres, founded in 1981, is a global biomedical company specializing in innovative acrylic resin-based medical devices primarily for orthopedics—including management of prosthetic joint infections, prosthesis fixation, vertebral augmentation, and cranioplasty—with commercialized, CE-certified, and ISO-certified products present in over 70 countries[1].

Therapeutic areas: NeurologyOtherInfectious DiseasesOrthopedics
Modalities: DeviceBiologic (acrylic resin-based implants and cements)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Tecres.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tecres.

Explore the full profile